LAmbre II LAA Occluder

· Lifetech Scientific (Shenzhen) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAmbre II LAA Occluder, covering 2026-02-04 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: FIM Study of the LAmbre™ II LAA Occluder in Non-Valvular AF Patients [NA]